Terms: = Head and neck cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4 AND Clinical Outcome
9 results:
1. Efficacy of Combined VEGFR1-3, PDGFα/β, and fgfr1-3 Blockade Using Nintedanib for Esophagogastric cancer.
Won E; Basunia A; Chatila WK; Hechtman JF; Chou JF; Ku GY; Chalasani SB; Boyar MS; Goldberg Z; Desai AM; Tuvy Y; Berger MF; Tang L; Kelsen DP; Schattner M; Ilson DH; Capanu M; Solit DB; Schultz N; Janjigian YY
Clin Cancer Res; 2019 Jul; 25(13):3811-3817. PubMed ID: 30952642
[TBL] [Abstract] [Full Text] [Related]
2. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
Salem ME; Puccini A; Xiu J; Raghavan D; Lenz HJ; Korn WM; Shields AF; Philip PA; Marshall JL; Goldberg RM
Oncologist; 2018 Nov; 23(11):1319-1327. PubMed ID: 29866946
[TBL] [Abstract] [Full Text] [Related]
3. Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory PI3K/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancer.
Starska K; Forma E; Lewy-Trenda I; Stasikowska-Kanicka O; Skóra M; Bryś M
Cell Oncol (Dordr); 2018 Jun; 41(3):253-268. PubMed ID: 29299828
[TBL] [Abstract] [Full Text] [Related]
4. fgfr1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma.
von Loga K; Kohlhaussen J; Burkhardt L; Simon R; Steurer S; Burdak-Rothkamm S; Jacobsen F; Sauter G; Krech T
PLoS One; 2015; 10(11):e0141867. PubMed ID: 26555375
[TBL] [Abstract] [Full Text] [Related]
5. 18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers?
Kendi AT; Corey A; Magliocca KR; Nickleach DC; Galt J; Switchenko JM; El-Deiry MW; Wadsworth JT; Hudgins PA; Saba NF; Schuster DM
Eur J Radiol; 2015 Jun; 84(6):1171-6. PubMed ID: 25816993
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma.
He LR; Liu MZ; Li BK; Rao HL; Liao YJ; Guan XY; Zeng YX; Xie D
BMC Cancer; 2009 Dec; 9():461. PubMed ID: 20028503
[TBL] [Abstract] [Full Text] [Related]
7. Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer.
Roesch-Ely M; Nees M; Karsai S; Ruess A; Bogumil R; Warnken U; Schnölzer M; Dietz A; Plinkert PK; Hofele C; Bosch FX
Oncogene; 2007 Jan; 26(1):54-64. PubMed ID: 16819514
[TBL] [Abstract] [Full Text] [Related]
8. p53 mutational spectra are different between squamous-cell carcinomas of the lip and the oral cavity.
Ostwald C; Gogacz P; Hillmann T; Schweder J; Gundlach K; Kundt G; Barten M
Int J Cancer; 2000 Oct; 88(1):82-6. PubMed ID: 10962443
[TBL] [Abstract] [Full Text] [Related]
9. Prediction of human oral cancer radiation responsiveness by histone (H3) mRNA in situ hybridization: a preliminary report.
Donoff RB; Todd R; Elovic A; Gallagher GT; Chou MY; Wong DT
J Oral Maxillofac Surg; 1998 Dec; 56(12):1410-6. PubMed ID: 9846539
[TBL] [Abstract] [Full Text] [Related]